Investigational PCSK9 Inhibitor Shows Positive Results in Phase 3 Study
Pfizer announced topline data for the Phase 3 SPIRE-AI (AutoInjector) trial where bococizumab given as a prefilled pen met its co-primary endpoints.
Pfizer announced topline data for the Phase 3 SPIRE-AI (AutoInjector) trial where bococizumab given as a prefilled pen met its co-primary endpoints.
The Endocrine Society has issued a statement advising clinicians to avoid administering compounded hormone medications to treat menopausal symptoms, female sexual dysfunction, and other hormone conditions.
Expecting mothers should make sure they get enough vitamin D exposure during the second trimester to reduce the child’s likelihood of developing asthma, according to new research by the University of Kansas published in the American Journal of Health Economics.
Coffee consumption may lower the risk of colorectal cancer, according to findings from a new study published in Cancer Epidemiology, Biomarkers & Prevention.
According to a new Centers for Disease Control and Prevention (CDC) report, the prevalence of autism spectrum disorder (ASD) has not largely changed from 2 years ago with a rate of 1 in 68 children (1.46%).
Cambrooke Therapeutics announced the launch of KetoVie Peptide, the first ketogenic hydrolyzed whey-based (peptides) formula for patients on a ketogenic diet with milk protein sensitivities and/or impaired digestive function.
Sleep problems in young adults may predict chronic pain and worsening pain severity over time, a new study published in PAIN has shown.
Researchers from Western Australia reported that seasonal influenza vaccinations may protect against stillbirth.
Drugs that were once considered safe for pregnant women with migraines may not be, according to researcher at Wake Forest Baptist Medical Center.
AstraZeneca announced that Brilinta (ticagrelor) is now preferred over clopidogrel for the management of patients with acute coronary syndrome (ACS) who have received a coronary stent and in non-ST elevation acute coronary syndrome (NSTE-ACS) patients treated with medical therapy alone.